MarketScreener Homepage > Equities > NASDAQ OMX STOCKHOLM > Hansa Biopharma AB (publ) HNSA SE0002148817

Report

Delayed NASDAQ OMX STOCKHOLM - 01/15 11:29:56 am
182.8	SEK		-5.72%

01/11

HANSA BIOPHARMA : Forecasts FY20 Operating Loss to Widen

01/11

HANSA BIOPHARMA : provides business update incl. certain key financials ahead of the JP Morgan Global Healthcare Conference

2020

HANSA BIOPHARMA : Biopharma to present at the 39th Annual J.P. Morgan Healthcare Conference

Upcoming events on HANSA BIOPHARMA AB (PUBL)

01/18/21 \| 04:10am		SEB Healthcare Seminar
02/04/21		FY 2020 Earnings Release
02/11/21		Vator Swiss Nordic Conference
03/09/21		Carnegie Nordic Healthcare Seminar

Past events on HANSA BIOPHARMA AB (PUBL)

01/14/21 \| 07:30am		JP Morgan Healthcare Conference
01/11/21 \| 06:00am		H.C. Wainwright Bioconnect Conference
01/11/21		Roadshow - JP Morgan
12/10/20		Roadshow - ABG

Upcoming sector events for HANSA BIOPHARMA AB (PUBL)

01/19/21		AKESO, INC. : R&D Day
01/20/21 \| 06:00am		EVOTEC SE : UniCredit Kepler Cheuvreux German Corporate Conference
01/21/21		SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. : Extraordinary Shareholders Meeting
01/21/21		BIOCON LIMITED : Q3 2021 Earnings Release

Past sector events for HANSA BIOPHARMA AB (PUBL)

01/14/21 \| 10:50am		IOVANCE BIOTHERAPEUTICS, INC. : JP Morgan Healthcare Conference
01/14/21 \| 09:10am		GALAPAGOS NV : JP Morgan Healthcare Conference
01/13/21 \| 03:40pm		HALOZYME THERAPEUTICS, INC. : JP Morgan Healthcare Conference
01/13/21		EVOTEC SE : Commerzbank German Investment Conference

Annual publications

Annual results		2015	2016	2017	2018	2019	2020 (e)
Sales M SEK	Released Forecast Spread	7,16 7,15 0,07%	2,58 3,19 -19%	3,44 2,98 16%	3,36 4,00 -16%	3,40 3,04 12%	35,8
Operating income (EBITDA) M SEK	Released Forecast Spread	-61,7	-110 -103 -6,8%	-172 -170 -1,5%	-233 -187 -24%	-352 -360 2,2%	-394
Operating profit (EBIT) M SEK	Released Forecast Spread	-66,2 -62,7 -5,7%	-111 -111 0,18%	-176 -170 -3,6%	-246 -192 -28%	-360 -357 -0,84%	-406
Pre-Tax Profit (EBT) M SEK	Released Forecast Spread	-66,3 -62,1 -6,7%	-111 -111 -0,28%	-177 -178 0,66%	-248 -222 -12%	-360 -356 -1,1%	-396
Net income M SEK	Released Forecast Spread	-66,3 -62,1 -6,8%	-111 -111 -0,26%	-177 -169 -4,4%	-248 -188 -32%	-360 -356 -1,2%	-396
EPS SEK	Released Forecast Spread	-2,13 -2,14 0,23%	-3,39 -3,42 0,73%	-4,97 -4,65 -6,8%	-6,47 -5,21 -24%	-9,00 -8,82 -2,0%	-9,40
Announcement Date		02/18/2016	02/15/2017	02/14/2018	02/08/2019	02/06/2020

Quarterly publications

Previous period

Next period

Quarterly results		2015 S2	2021 S1 (e)	2021 S2 (e)
Sales M SEK	Released Forecast Spread	2,09 3,90 -47%	33,0	48,0
Operating income (EBITDA) M SEK	Released Forecast Spread	-33,0 -26,1 -26%	-247	-282
Operating profit (EBIT) M SEK	Released Forecast Spread	-33,0 -25,1 -32%	-246	-281
Pre-Tax Profit (EBT) M SEK	Released Forecast Spread	-33,1 -25,1 -32%	-246	-281
Net income	Released Forecast Spread	-1,02 -0,97 -5,2%	-6,00	-6,00
Announcement Date		02/18/2016

Net sales (Year) - Rate of surprise

EPS (Year) - Rate of surprise

Net sales (Quarter) - Rate of surprise

EPS (Quarter) - Rate of surprise